Copenhagen, Capital Region of Denmark, Denmark
As Senior Vice President and Head of Medical and Translational Science at Novo Nordisk, I lead the team that set the strategic direction of our clinical development programs translating our scientific discoveries into best-in-class treatments. We ensure that the patient voice is part of shaping all that we do at Novo Nordisk and we are responsible for designing clinical programmes that will generate the evidence and insights we need to deliver for patients. As Chief Medical Officer at Novo Nordisk, I ensure that our patient safety and ethical standards are at the forefront of our initiatives, and that our mission to advance treatments for the patients we serve is ingrained across the organisation. My commitment is to drive patient-centered solutions that translate scientific insights into impactful and safe therapies for those we serve with the mission of providing them a better future. This, together with my clinical and scientific experience as consultant endocrinologist and professor of clinical endocrinology are what drive me in my leadership. My research has focused on cardio-metabolic diseases and the regulation of appetite and food intake in man. I hold an MD and a PhD from the University of Copenhagen, acted as the Director of Center for Clinical Metabolic Research at Gentofte Hospital for ~15 years, have published more than 550 peer-reviewed scientific publications, supervised more than 50 PhD fellows and have received several awards and honours (e.g., EASD’s Minkowski Prize 2019). From numerous international scientific collaborations and my research stays abroad (Southwestern Medical Center, University of Texas, Dallas, USA, 1999/2000, and Victor Chang Cardiac Research Institute, Sydney, Australia, 2008/2009), I have an international outlook that helps me in directing and managing collaborations with colleagues across the Novo Nordisk organization and external stakeholders around the globe.
As Senior Medical Officer in Novo Nordisk, I strive contributing to improve the lives of people living with metabolic diseases. My goal is to drive the further development of clinical science and medical excellence across the Novo Nordisk organization focusing on unmet medical needs. My clinical and scientific experience from previous roles as consultant endocrinologist and professor of clinical endocrinology help me define and drive diabetes and obesity strategies including scientific innovation in Novo Nordisk. My research has focused on metabolic diseases and the regulation of appetite and food intake in man. I hold an MD and a PhD from the University of Copenhagen, acted as the Director of Center for Clinical Metabolic Research at Gentofte Hospital for ~15 years, have published more than 500 peer-reviewed scientific publications, supervised more than 50 PhD fellows and have received several awards and honors (e.g., EASD’s Minkowski Prize 2019). From numerous international scientific collaborations and my research stays abroad (Southwestern Medical Center, University of Texas, Dallas, USA, 1999/2000) and Victor Chang Cardiac Research Institute, Sydney, Australia, 2008/2009), I have an international outlook that helps me directing and enforcing collaborations with colleagues across the Novo Nordisk organization and external stakeholders around the globe. I use my medical voice interacting with governance bodies, supporting and advising internal stakeholders on clinical science and unmet medical needs in diabetes and obesity. I endeavor integrating my desire to provide a better future for people living with diabetes and/or obesity and Novo Nordisk’s innovative approaches to ensure that our pioneering solutions across the value chain improve patient outcomes and society. My professional motto has always been “Bring patients to science and science to patients” – in Novo Nordisk, I strive to deliver on that.